Current Clinical Approaches to the Treatment of Major Covid-19 Pandemic and the Effectiveness of Immunoboosters and Safety Precautions as Methods of Prevention.

Virmani Mayank; Kaur M; eep

Accueil du journal

Indexé dans

Infrastructure nationale des connaissances en Chine (CNKI)
Cosmos SI
Répertoire d'indexation des revues de recherche (DRJI)
OCLC - WorldCat
Publions
Fondation genevoise pour la formation et la recherche médicales
Pub européen
Google Scholar
SHERPA ROMÉO

Partager cette page

Abstrait

Current Clinical Approaches to the Treatment of Major Covid-19 Pandemic & the Effectiveness of Immunoboosters and Safety Precautions as Methods of Prevention.

Virmani Mayank, Kaur Mandeep

COVID-19 is declared as a major pandemic with 302,460 deaths and 1,697,934 people have recovered, as of March 13th, 2020. Various clinical trials are being conducted on antiviral drugs- i.e. resemdivir, anti-parasitic drugs-i.e. ivermectin, plasma therapy, and many more. However, there are no accurate or desired outcomes achieved till now. Some drugs pass in-vitro studies and some pass all clinical trials but they also have to lead to Adverse Drug Reactions (ADR’S) or complications. No particular approved treatment or vaccines to treat COVID -19 have been implemented for a full recovery. So, precautionary measures are vital as a method to protect you from this disease that has been showing an increasing number of cases day by day. Natural immune boosters are also helpful as a protective barrier to fight against COVID-19. Social distancing and proper hand hygiene and sanitation are also important safety measures during this pandemic.

Recherche sur les systèmes et les politiques de santé

Indexé dans

Partager cette page

Abstrait

Current Clinical Approaches to the Treatment of Major Covid-19 Pandemic & the Effectiveness of Immunoboosters and Safety Precautions as Methods of Prevention.